David Pyott was raised in India and Scotland. An early love of languages led him to work and study in mainland Europe, while pursuing a BA in German language and literature at the University of Edinburgh. Later, he added a diploma in European and International Law from the University of Amsterdam and an MBA from the London Business School. Pyott began his career in the City of London, handling German banking clients for Kleinwort Benson. He soon moved on to Switzerland, where he worked in the nutrition division of Sandoz (later Novartis, after merging with Ciba-Geigy). Various international postings followed before he joined Allergan in the United States in 1998, as President and CEO. Pyott now serves as Chairman of the Board, as well. In the last ten years, he has overseen the company’s growth in ‘medical aesthetics.’ Allergan’s Botox and Juvéderm products are important revenue generators alongside the company’s other specialty ophthalmic products that continue to enjoy great commercial success. Pyott is currently active on the boards of Edwards Lifesciences Corporation and Avery Dennison Corporation. He has also served as a director for the California Healthcare Initiative and the Biotechnology Industry Organization. He was honored in 2006 by Queen Elizabeth II and made a Commander of the British Empire for services to British business excellence in the United States.
Access this interview